Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.38M | 12.02M | 11.82M | 10.37M | 5.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.38M | 12.02M | 11.82M | 10.37M | 5.30M |
| Cost of Revenue | 2.50M | 2.88M | 5.13M | 1.97M | 1.11M |
| Gross Profit | 10.88M | 9.14M | 6.69M | 8.40M | 4.20M |
| SG&A Expenses | 4.09M | 4.82M | 4.85M | 4.61M | 1.32M |
| Depreciation & Amortization | 1.81M | 1.82M | 1.51M | 1.93M | 292.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.39M | 9.55M | 11.49M | 8.50M | 2.72M |
| Operating Income | 4.99M | 2.47M | 334.00K | 1.87M | 2.59M |
| Income Before Tax | 6.41M | 1.89M | -2.85M | 326.00K | 2.52M |
| Income Tax Expenses | 512.00K | -737.00K | -6.20M | 43.00K | -480.00K |
| Earnings from Continuing Operations | 5.89M | 2.62M | 3.34M | 283.00K | 3.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.89M | 2.62M | 3.34M | 283.00K | 3.00M |
| EBIT | 4.99M | 2.47M | 334.00K | 1.87M | 2.59M |
| EBITDA | 6.80M | 4.30M | 1.67M | 3.80M | 2.88M |
| EPS Basic | 0.23 | 0.10 | 0.13 | 0.01 | 0.12 |
| Normalized Basic EPS | 0.15 | 0.05 | -0.05 | 0.05 | 0.07 |
| EPS Diluted | 0.22 | 0.10 | 0.13 | 0.01 | 0.12 |
| Normalized Diluted EPS | 0.15 | 0.05 | -0.05 | 0.05 | 0.07 |
| Average Basic Shares Outstanding | 25.87M | 25.61M | 25.72M | 25.17M | 24.11M |
| Average Diluted Shares Outstanding | 26.51M | 26.20M | 25.72M | 25.69M | 24.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |